Thus, although it remains unclear whether these mutations play any role in promoting cancer progression, like Pno1-KKKF, the cancer-associated Pno1 mutants are expected to bypass Rio1, leading to the release of immature ribosomes into the translating pool and resulting in translation fidelity defects, as we have shown in yeast cells. Here, PNO1 is linked to cancer.